Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2016, Article ID 5781579, 9 pages
http://dx.doi.org/10.1155/2016/5781579
Research Article

The Ginkgo biloba Extract Reverses the Renal Effects of Titanium Dioxide Nanoparticles in Adult Male Rats

1Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, 20131 Aguascalientes, AGS, Mexico
2Departamento de Microbiología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, 20131 Aguascalientes, AGS, Mexico

Received 31 October 2015; Accepted 8 February 2016

Academic Editor: Andrei Surguchov

Copyright © 2016 Carlos Enrique Escárcega-González et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Giebish and E. Windhager, “Organization of the urinary system,” in Medical Physiology, W. F. Boron and E. L. Boulpaep, Eds., pp. 747–766, Saunders, Elsevier Science, Philadelphia, Pa, USA, 2008. View at Google Scholar
  2. W. Feng, B. Wang, and Y. Zhao, “Nanotoxicity of metal oxide nanoparticles in vivo,” in Nanotoxicity, S. C. Sahu and D. A. Casciano, Eds., chapter 13, pp. 247–269, John Wiley & Sons, Chichester, UK, 2009. View at Publisher · View at Google Scholar
  3. H. Shi, R. Magaye, V. Castranova, and J. Zhao, “Titanium dioxide nanoparticles: a review of current toxicological data,” Particle and Fibre Toxicology, vol. 10, no. 1, article 15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. Shvedova, V. E. Kagan, and B. Fadeel, “Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems,” Annual Review of Pharmacology and Toxicology, vol. 50, pp. 63–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Barillet, A. Simon-Deckers, N. Herlin-Boime et al., “Toxicological consequences of TiO2, SiC nanoparticles and multi-walled carbon nanotubes exposure in several mammalian cell types: an in vitro study,” Journal of Nanoparticle Research, vol. 12, no. 1, pp. 61–73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. B. L'Azou, J. Jorly, D. On et al., “In vitro effects of nanoparticles on renal cells,” Particle and Fibre Toxicology, vol. 5, article 22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Pujalté, I. Passagne, B. Brouillaud et al., “Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells,” Particle and Fibre Toxicology, vol. 8, article 10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Šebeková, M. Dušinská, K. Simon Klenovics et al., “Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats,” Nanotoxicology, vol. 8, no. 2, pp. 142–157, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Shi, R. Magaye, V. Castranova, and J. Zhao, “Titanium dioxide nanoparticles: a review of current toxicological data,” Particle and Fibre Toxicology, vol. 10, article 15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Fabian, R. Landsiedel, L. Ma-Hock, K. Wiench, W. Wohlleben, and B. van Ravenzwaay, “Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats,” Archives of Toxicology, vol. 82, no. 3, pp. 151–157, 2008. View at Publisher · View at Google Scholar
  11. J. Wang, G. Zhou, C. Chen et al., “Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration,” Toxicology Letters, vol. 168, no. 2, pp. 176–185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. W. E. Stroo and J. B. Hook, “Enzymes of renal origin in urine as indicators of nephrotoxicity,” Toxicology and Applied Pharmacology, vol. 39, no. 3, pp. 423–434, 1977. View at Publisher · View at Google Scholar · View at Scopus
  13. W. G. Guder and B. D. Ross, “Enzyme distribution along the nephron,” Kidney International, vol. 26, no. 2, pp. 101–111, 1984. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. Kenny, A. G. Booth, S. G. George et al., “Dipeptidyl peptidase IV, a kidney brush-border serine peptidase,” Biochemical Journal, vol. 157, no. 1, pp. 169–182, 1976. View at Publisher · View at Google Scholar
  15. H.-J. Choi, Y.-J. Yoon, Y.-K. Kwon et al., “Patterns of gene and metabolite define the effects of extracellular osmolality on kidney collecting duct,” Journal of Proteome Research, vol. 11, no. 7, pp. 3816–3828, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Beer, “Herbal medicines used in kidney diseases in Europe,” Iranian Journal of Kidney Diseases, vol. 5, no. 2, pp. 82–85, 2011. View at Google Scholar · View at Scopus
  17. T. E. Brinkley, J. F. Lovato, A. M. Arnold et al., “Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women,” American Journal of Hypertension, vol. 23, no. 5, pp. 528–533, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P.-C. Chan, Q. Xia, and P. P. Fu, “Ginkgo biloba leave extract: biological, medicinal, and toxicological effects,” Journal of Environmental Science and Health Part C: Environmental Carcinogenesis and Ecotoxicology Reviews, vol. 25, no. 3, pp. 211–244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Culmsee and J. Krieglstein, “Ischaemic brain damage after stroke: new insights into efficient therapeutic strategies. International Symposium on Neurodegeneration and Neuroprotection,” EMBO Reports, vol. 8, no. 2, pp. 129–133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. H. P. Fransen, S. M. G. J. Pelgrom, B. Stewart-Knox, D. de Kaste, and H. Verhagen, “Assessment of health claims, content, and safety of herbal supplements containing Ginkgo biloba,” Food & Nutrition Research, vol. 54, article 5221, 2010. View at Google Scholar · View at Scopus
  21. S. Mahadevan and Y. Park, “Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses,” Journal of Food Science, vol. 73, no. 1, pp. R14–R19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. L. Ponto and S. K. Schultz, “Ginkgo biloba extract: review of CNS effects,” Annals of Clinical Psychiatry, vol. 15, no. 2, pp. 109–119, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, X. Wang, L. Wang, M. Yu, and X. Han, “Interactions of the baicalin and baicalein with bilayer lipid membranes investigated by cyclic voltammetry and UV-Vis spectroscopy,” Bioelectrochemistry, vol. 95, pp. 29–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Deng and S. W. Zito, “Development and validation of a gas chromatographic-mass spectrometric method for simultaneous identification and quantification of marker compounds including bilobalide, ginkgolides and flavonoids in Ginkgo biloba L. extract and pharmaceutical preparations,” Journal of Chromatography A, vol. 986, no. 1, pp. 121–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. M.-J. Dubber and I. Kanfer, “High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 3, pp. 303–309, 2004. View at Google Scholar · View at Scopus
  26. C.-Y. Li, C.-H. Lin, C.-C. Wu, K.-H. Lee, and T.-S. Wu, “Efficient 1H nuclear magnetic resonance method for improved quality control analyses of Ginkgo constituents,” Journal of Agricultural and Food Chemistry, vol. 52, no. 12, pp. 3721–3725, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. T. A. van Beek and P. Montoro, “Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals,” Journal of Chromatography A, vol. 1216, no. 11, pp. 2002–2032, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Yao, G.-S. Zhou, Y.-P. Tang et al., “Simultaneous quantification of flavonol glycosides, terpene lactones, biflavones, proanthocyanidins, and ginkgolic acids in ginkgo biloba leaves from fruit cultivars by ultrahigh-performance liquid chromatography coupled with triple quadrupole mass spectrometry,” BioMed Research International, vol. 2013, Article ID 582591, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Song, D. Liu, L. Feng, Z. Zhang, X. Jia, and W. Xiao, “Protective effect of standardized extract of Ginkgo biloba against cisplatin-induced nephrotoxicity,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 846126, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. W.-D. Chen, Y. Liang, L. Xie, T. Lu, X.-D. Liu, and G.-J. Wang, “Pharmacokintics of the Ginkgo Bfollowing intravenous administration of Ginkgo B emulsion in rats,” Biological and Pharmaceutical Bulletin, vol. 30, no. 1, pp. 1–5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Cárdenas, M. C. Martínez, F. Jaramillo et al., “The protective effect of Ginkgo biloba on the damage induced by methyl parathion in cerebellar granule cells of rat,” Revista Mexicana de Ciencias Farmacéuticas, vol. 41, no. 4, pp. 37–42, 2010. View at Google Scholar
  32. J. Kleijnen and P. Knipschild, “Ginkgo biloba for cerebral insufficiency,” British Journal of Clinical Pharmacology, vol. 34, no. 4, pp. 352–358, 1992. View at Publisher · View at Google Scholar · View at Scopus
  33. W. R. Zhang, T. Hayashi, H. Kitagawa et al., “Protective effect of Ginkgo extract on rat brain with transient middle cerebral artery occlusion,” Neurological Research, vol. 22, no. 5, pp. 517–521, 2000. View at Google Scholar · View at Scopus
  34. J. Vesper and K. D. Hänsgen, “Efficacy of Ginkgo biloba in 90 outpatients with cerebral insufficiency caused by old age: results of a placebo-controlled double-blind trial,” Phytomedicine, vol. 1, no. 1, pp. 9–16, 1994. View at Publisher · View at Google Scholar
  35. D. O. Kennedy, A. B. Scholey, and K. A. Wesnes, “The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers,” Psychopharmacology, vol. 151, no. 4, pp. 416–423, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. P. L. Le Bars, M. M. Katz, N. Berman, T. M. Itil, A. M. Freedman, and A. F. Schatzberg, “A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia,” The Journal of the American Medical Association, vol. 278, no. 16, pp. 1327–1332, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Peters, M. Kieser, and U. Hölscher, “Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication—a placebo-controlled, double-blind multicenter trial,” European Journal of Vascular Medicine, vol. 27, no. 2, pp. 106–110, 1998. View at Google Scholar
  38. B. J. Diamond, S. C. Shiflett, N. Feiwel et al., “Ginkgo biloba extract: mechanisms and clinical indications,” Archives of Physical Medicine and Rehabilitation, vol. 81, no. 5, pp. 668–678, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. M. U. R. Naidu, A. A. Shifow, K. V. Kumar, and K. S. Ratnakar, “Ginkgo biloba extract ameliorates gentamicin-induced nephrotoxicity in rats,” Phytomedicine, vol. 7, no. 3, pp. 191–197, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. M. F. Abd-Ellah and A. D. Mariee, “Ginkgo biloba leaf extract (EGb 761) diminishes adriamycin-induced hyperlipidaemic nephrotoxicity in rats: association with nitric oxide production,” Biotechnology and Applied Biochemistry, vol. 46, no. 1, pp. 35–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Orlowski and A. Meister, “γ-Glutamyl-p-nitroanilide: a new convenient substrate for determination of L- and D-γ-glutamyltranspeptidase activities,” Biochimica et Biophysica Acta, vol. 73, pp. 679–681, 1963. View at Google Scholar
  42. T. Yoshimoto, M. Fischl, R. C. Orlowski, and R. Walter, “Post-proline cleaving enzyme and post-proline dipeptidyl aminopeptidase. Comparison of two peptidases with high specificity for proline residues,” The Journal of Biological Chemistry, vol. 253, no. 10, pp. 3708–3716, 1978. View at Google Scholar · View at Scopus
  43. M. Jaffe, “Ueber den niederschlag, welchen Pikrinsäure in normalem Harn erzeugt und über eine neue reaction des Kreatinins,” Biological Chemistry, vol. 10, no. 5, pp. 391–400, 1886. View at Publisher · View at Google Scholar
  44. O. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of biological chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  45. K. Volkovova, R. D. Handy, M. Staruchova et al., “Health effects of selected nanoparticles in vivo: liver function and hepatotoxicity following intravenous injection of titanium dioxide and Na-oleate-coated iron oxide nanoparticles in rodents,” Nanotoxicology, vol. 9, supplement 1, pp. 95–105, 2015. View at Publisher · View at Google Scholar
  46. X. Chen and S. S. Mao, “Titanium dioxide nanomaterials: synthesis, properties, modifications and applications,” Chemical Reviews, vol. 107, no. 7, pp. 2891–2959, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Arora, J. M. Rajwade, and K. M. Paknikar, “Nanotoxicology and in vitro studies: the need of the hour,” Toxicology and Applied Pharmacology, vol. 258, no. 2, pp. 151–165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Iavicoli, V. Leso, L. Fontana, and A. Bergamaschi, “Toxicological effects of titanium dioxide nanoparticles: a review of in vitro mammalian studies,” European Review for Medical and Pharmacological Sciences, vol. 15, no. 5, pp. 481–508, 2011. View at Google Scholar · View at Scopus
  49. C. Jin, Y. Tang, F. G. Yang et al., “Cellular toxicity of TiO2 nanoparticles in anatase and rutile crystal phase,” Biological Trace Element Research, vol. 141, no. 1–3, pp. 3–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Smulders, K. Luyts, G. Brabants et al., “Toxicity of nanoparticles embedded in paints compared to pristine nanoparticles, in vitro study,” Toxicology Letters, vol. 232, no. 2, pp. 333–339, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Smulders, K. Luyts, G. Brabants et al., “Toxicity of nanoparticles embedded in paints compared with pristine nanoparticles in mice,” Toxicological Sciences, vol. 141, no. 1, pp. 132–140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. H. C. Fischer and W. C. Chan, “Nanotoxicity: the growing need for in vivo study,” Current Opinion in Biotechnology, vol. 18, no. 6, pp. 565–571, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. I. Iavicoli, V. Leso, and A. Bergamaschi, “Toxicological effects of titanium dioxide nanoparticles: a review of in vivo studies,” Journal of Nanomaterials, vol. 2012, Article ID 964381, 36 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Arora, T. M. Byrem, M. G. Nair, and G. M. Strasburg, “Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids,” Archives of Biochemistry and Biophysics, vol. 373, no. 1, pp. 102–109, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Heinonen and W. Gaus, “Cross matching observations on toxicological and clinical data for the assessment of tolerability and safety of Ginkgo biloba leaf extract,” Toxicology, vol. 327, no. 1, pp. 95–115, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Cieślik-Boczula, J. Maniewska, G. Grynkiewicz, W. Szeja, A. Koll, and A. B. Hendrich, “Interaction of quercetin, genistein and its derivatives with lipid bilayers—an ATR IR-spectroscopic study,” Vibrational Spectroscopy, vol. 62, pp. 64–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. A. B. Hendrich, “Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds,” Acta Pharmacologica Sinica, vol. 27, no. 1, pp. 27–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. H. I. Ingólfsson, P. Thakur, K. F. Herold et al., “Phytochemicals perturb membranes and promiscuously alter protein function,” ACS Chemical Biology, vol. 9, no. 8, pp. 1788–1798, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Y. A. Lehtonen, H. Adlercreutz, and P. K. J. Kinnunen, “Binding of daidzein to liposomes,” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 1285, no. 1, pp. 91–100, 1996. View at Publisher · View at Google Scholar · View at Scopus
  60. K.-L. Liao and M.-C. Yin, “Individual and combined antioxidant effects of seven phenolic agents in human erythrocyte membrane ghosts and phosphatidylcholine liposome systems: importance of the partition coefficient,” Journal of Agricultural and Food Chemistry, vol. 48, no. 6, pp. 2266–2270, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Ollila, K. Halling, P. Vuorela, H. Vuorela, and J. P. Slotte, “Characterization of flavonoid-biomembrane interactions,” Archives of Biochemistry and Biophysics, vol. 399, no. 1, pp. 103–108, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. P. I. Oteiza, A. G. Erlejman, S. V. Verstraeten, C. L. Keen, and C. G. Fraga, “Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface?” Clinical and Developmental Immunology, vol. 12, no. 1, pp. 19–25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. B. Pawlikowska-Pawlega, L. E. Misiak, B. Zarzyka et al., “Modification of membranes by quercetin, a naturally occurring flavonoid, via its incorporation in the polar head group,” BBA-Biomembranes, vol. 1768, no. 9, pp. 2195–2204, 2007. View at Google Scholar
  64. B. Pawlikowska-Pawlęga, L. E. Misiak, B. Zarzyka, R. Paduch, A. Gawron, and W. I. Gruszecki, “Localization and interaction of genistein with model membranes formed with dipalmitoylphosphatidylcholine (DPPC),” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 1818, no. 7, pp. 1785–1793, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Raghunathan, Y. Zubovski, R. M. Venable, R. W. Pastor, J. F. Nagle, and S. Tristram-Nagle, “Structure and elasticity of lipid membranes with genistein and daidzein bioflavinoids using X-ray scattering and MD simulations,” The Journal of Physical Chemistry B, vol. 116, no. 13, pp. 3918–3927, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. H. A. Scheidt, A. Pampel, L. Nissler, R. Gebhardt, and D. Huster, “Investigation of the membrane localization and distribution of flavonoids by high-resolution magic angle spinning NMR spectroscopy,” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 1663, no. 1-2, pp. 97–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Tsuchiya, M. Nagayama, T. Tanaka, M. Furusawa, M. Kashimata, and H. Takeuchi, “Membrane-rigidifying effects of anti-cancer dietary factors,” BioFactors, vol. 16, no. 3-4, pp. 45–56, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. V. Ajdžanović, I. Spasojević, B. Filipović, B. Šošić-Jurjević, M. Sekulić, and V. Miloševic, “Effects of genistein and daidzein on erythrocyte membrane fluidity: an electron paramagnetic resonance study,” Canadian Journal of Physiology and Pharmacology, vol. 88, no. 4, pp. 497–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Cyboran, J. Oszmiański, and H. Kleszczyńska, “Interaction between plant polyphenols and the erythrocyte membrane,” Cellular and Molecular Biology Letters, vol. 17, no. 1, pp. 77–88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Pawlikowska-Pawlęga, W. I. Gruszecki, L. E. Misiak, and A. Gawron, “The study of the quercetin action on human erythrocyte membranes,” Biochemical Pharmacology, vol. 66, no. 4, pp. 605–612, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Fiorucci, J. Golebiowski, D. Cabrol-Bass, and S. Antonczak, “DFT study of quercetin activated forms involved in antiradical, antioxidant, and prooxidant biological processes,” Journal of Agricultural and Food Chemistry, vol. 55, no. 3, pp. 903–911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Paulíková and E. Berczeliová, “The effect of quercetin and galangin on glutathione reductase,” Biomedical Papers of Medical Faculty of University Palacky Olomouc Czech Republic, vol. 149, no. 2, pp. 497–500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Guan, D. Qian, H. Ren et al., “Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats,” Journal of Ethnopharmacology, vol. 155, no. 1, pp. 758–768, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. R. H. Liu, “Potential synergy of phytochemicals in cancer prevention: mechanism of action,” Journal of Nutrition, vol. 134, no. 12, pp. 3479S–3485S, 2004. View at Google Scholar · View at Scopus
  75. Y. Yang, Z. Zhang, S. Li, X. Ye, X. Li, and K. He, “Synergy effects of herb extracts: pharmacokinetics and pharmacodynamic basis,” Fitoterapia, vol. 92, no. 2, pp. 133–147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Wagner, “Synergy research: approaching a new generation of phytopharmaceuticals,” Fitoterapia, vol. 82, no. 1, pp. 34–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. B. Pahari, S. Chakraborty, S. Chaudhuri, B. Sengupta, and P. K. Sengupta, “Binding and antioxidant properties of therapeutically important plant flavonoids in biomembranes: insights from spectroscopic and quantum chemical studies,” Chemistry and Physics of Lipids, vol. 165, no. 4, pp. 488–496, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. C. E. Escárcega-González, Estudio de la toxicidad de nanopartículas de TiO2 y TiO2/Ag en ratas wistar machos [Thesis for Master in Science (Toxicology)], Departamento de Farmacología y Fisiología y Departamento de Departamento de Química. Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, México, 2012.
  79. H. M. Bolt, R. Marchan, and J. G. Hengstler, “Nanotoxicology and oxidative stress control: cutting-edge topics in toxicology,” Archives of Toxicology, vol. 86, no. 11, pp. 1629–1635, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. M. E. Bruno, D. R. Tasat, E. Ramos et al., “Impact through time of different sized titanium dioxide particles on biochemical and histopathological parameters,” Journal of Biomedical Materials Research Part A, vol. 102, no. 5, pp. 1439–1448, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. B. Halamoda Kenzaoui, C. Chapuis Bernasconi, and L. Juillerat-Jeanneret, “Stress reaction of kidney epithelial cells to inorganic solid-core nanoparticles,” Cell Biology and Toxicology, vol. 29, no. 1, pp. 39–58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Hussain, S. Boland, A. Baeza-Squiban et al., “Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount,” Toxicology, vol. 260, no. 1–3, pp. 142–149, 2009. View at Publisher · View at Google Scholar · View at Scopus